All In Biotech

Drug Trial Radar · NCT05774184

A Study of CDX-0159 in Patients With Eosinophilic Esophagitis

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults With Active Eosinophilic Esophagitis (The "EvolvE" Study)

Last checked: Nov 20, 2026Latest source record: May 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

86

Actual

Start

Jun 1, 2023

Primary completion

Jun 4, 2025

Study completion Jan 23, 2026

Sponsor

Lead sponsor
Celldex TherapeuticsIndustry
Sponsor type
Industry
First posted
Mar 17, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adult Eosinophilic Esophagitis patients.

Conditions

  • Eosinophilic Esophagitis

Interventions

  • barzolvolimabBiological

    subcutaneous administration

  • Matching PlaceboDrug

    subcutaneous administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Absolute change from baseline to Week 12 in peak intraepithelial mast cell (PMC) count (PMC/hpf).Time frame: From baseline to Visit 6 (Week 12)

Locations

45 sites in 8 countries. Site status is shown where the registry gives one.

  • AllerVie Clinical Research

    Birmingham, Alabama

  • One of a Kind Clinical Research Center

    Scottsdale, Arizona

  • GI Alliance- Arizona Digestive Health- Sun City

    Sun City, Arizona

  • Del Sol Research Management, LLC

    Tucson, Arizona

  • GW Research Inc.

    Chula Vista, California

  • Connecticut Clinical Research Institute, LLC

    Bristol, Connecticut

  • ENCORE Borland Groover Clinical Research

    Jacksonville, Florida

  • Gastroenterology of Greater Orlando

    Orange City, Florida

  • Treasure Valley Medical Research

    Boise, Idaho

  • Northwestern University

    Chicago, Illinois

  • University of Iowa

    Iowa City, Iowa

  • University of Kansas Medical Center (KUMC)

    Kansas City, Kansas

  • Tandem Clinical Research

    Marrero, Louisiana

  • Boston Specialists - Boston Food Allergy Center

    Boston, Massachusetts

  • NYU Langone Health

    New York, New York

  • University of North Carolina (UNC) Hospitals

    Chapel Hill, North Carolina

  • Duke University Medical Center

    Durham, North Carolina

  • The Clinical Trials Network, LLC

    Willoughby, Ohio

  • The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center

    Hershey, Pennsylvania

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Vanderbilt University Medical Center-GI Clinical Research Program

    Nashville, Tennessee

  • Advanced Research Institute - Ogden

    Ogden, Utah

  • Care Access Research

    Salt Lake City, Utah

  • University of Utah

    Salt Lake City, Utah

  • St Vincent's Hospital Melbourne

    Melbourne, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • The Alfred Hospital

    Melbourne, Victoria, Australia

  • University of Calgary

    Calgary, Alberta, Canada

  • PerCuro Clinical Research Ltd.

    Victoria, British Columbia, Canada

  • Universitaetsklinikum Augsburg

    Augsburg, Germany

  • Klinikum Region Hannover GmbH Burgwedel

    Hanover, Germany

  • Universitaetsklinikum Magdeburg A.oe.R.

    Magdeburg, Germany

  • IRCCS Ospedale San Raffaele

    Milan, Italy

  • Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore

    Rome, Italy

  • Istituto Clinico Humanitas

    Rozzano, Italy

  • Azienda Ospedaliera Universitaria OO.RR. San Giovanni di Dio Ruggi d'Aragona-Plesso "Ruggi"

    Salerno, Italy

  • Azienda Ospedaliera - Universitaria Integrata di Verona - Ospedale Borgo Roma

    Verona, Italy

  • Centrum Medyczne Med-Gastr Sp. z o.o.

    Lodz, Poland

  • WIP Warsaw IBD Point Profesor Kierkus

    Warsaw, Poland

  • Wojskowy Instytut Medyczny - Panstwowy Instytut Badawczy, Klinika Gastroenterologii i Chorob

    Warsaw, Poland

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.